Saskatchewan to expand cystic fibrosis medication on Aug. 1
Trifakta works by targeting specific genetic mutations that cause CF. The mutation impacts about 90 per cent of CF patients.
Trifakta works by targeting specific genetic mutations that cause CF. The mutation impacts about 90 per cent of CF patients.